This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the FDAs top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agencys ability to review and potentially approve such treatments. The post Ouster of Peter Marks & Mass FDA Layoffs Have Biotech Sector Bracing for Regulatory Disruptions appeared first on MedCity News.
Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy goals. This program came from a $950 million acquisition in 2019 that marked Vertexs entry into type 1 diabetes. The post Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal appeared first on MedCity News.
Todd Crowder’s path into medical sales wasn’t just a career choice it was a legacy in the making. Growing up with a father who built a prolific career at Ethicon, Todd was immersed in the industry from an early age. But instead of simply following in his father’s footsteps, he forged his own path, bringing a unique blend of military discipline, strategic thinking, and entrepreneurial drive into the world of medical sales.
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
True patient engagement creates ripple effects that transform both clinical outcomes and business results in a measurable way. Measuring engagement isnt just about numbersits about the lives that are touched and the improvements made through strategic, thoughtful approaches to patient communication. The concept of patient engagement has evolved significantly over the past 25 years.
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
52
52
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
Introduction Weekends may be synonymous with relaxation, but for pharma marketing professionals, they offer an unmatched window to recalibrate. When deadlines arent looming and inboxes arent overflowing, theres finally time to revisit trends, read strategy insights, and uncover tools to elevate your marketing game. The Pharma Marketing Network serves as an ideal destination for this kind of weekend deep-dive.
Why Real, Measurable Impact Can Only Come from Getting Close The advertising landscape is undergoing a seismic shift. As network agencies navigate uncharted territoriesmerging, rebranding, mounting margin pressures, and laying off thousandsthey are being forced to spend time and energy on things other than serving clients and growing their talent base.
Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Isomorphic Labs financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News.
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.
Digitas Healths Scott Raidel and Erica Rivera give us their insight on the future of blended learning for healthcare providers. SCOTT RAIDEL Chief Medical Officer Digitas Health ERICA RIVERA SVP, Engagement Strategy Digitas Health At the forefront of the industrys work, there is a desire to develop effective and tangible learning strategies for healthcare providers (HCPs).
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Trimming your marketing budget might seem like a quick way to cut costs, but it can hurt your healthcare business more than you thinkespecially during economic uncertainty. While the U.S. economy remains numerically strong, 53%of Americans think its on the wrong track. With uncertainty surrounding impending tariffs, inflation, a tightening labor market, and rising healthcare costs, consumer confidence is beginning to dip.
By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves health outcomes, and ensures cost-effective care for the communities they serve. The post Bridging the AI Gap in Local Health: Practical Steps for Adoption appeared first on MedCity News.
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Why Pharmas AI Strategy Must Evolve AI is everywhere in pharma. Companies are running pilots, testing AI in sales, marketing, and market access. Some are seeing results; many are not. The industry is at a breaking point. Over the last year or so, AI has been treated as an experimentpromising but not critical. That mindset is shifting as AI is now creating genuine business outcomes not only in drug discovery but also in commercialization.
Pharmaceutical marketing is evolving rapidly, driven by technological advancements, shifting doctor preferences, and heightened regulatory scrutiny. As we step into 2025, here are the key trends shaping the future of pharmaceutical marketing. AI-Driven Personalization in Doctor Engagement* Artificial Intelligence (AI) is transforming the way pharmaceutical brands interact with healthcare professionals (HCPs).
We must consider the broader social and structural context recognizing that poverty, social deprivation, and economic instability are not merely relevant factors, but necessary considerations in developing effective, equitable interventions. The post From Transfers to Treatment: Bridging Social Policy and Substance Use Treatment appeared first on MedCity News.
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Introduction Pharmaceutical marketing is entering a new era in 2025, driven by rapid advancements in technology, evolving patient expectations, and tighter compliance demands. As industry leaders adapt to digital-first communication and omnichannel engagement, the need for smart, scalable, and strategic marketing tactics is more urgent than ever. Whether you’re launching a new branded drug or optimizing an established portfolio, staying ahead of the curve in pharmaceutical marketing has be
A Smarter Approach to Pharma Marketing Pharma marketing is evolving rapidly as artificial intelligence (AI) and analytics make it easier to interpret health datasuch as insurance claims, lab results, and patient recordswhile also leveraging engagement data to refine outreach strategies. Rather than relying on broad outreach, marketers can now use data-driven insights to identify the right audience and craft messages that resonate.
As leaders, we often talk about our teams in terms of productivity, performance, and results. But lets take a step back: how often do we define our employees as people first? In a world that emphasizes output, its easy to forget that behind every task and every deadline is a human being with unique skills, dreams, and challenges. When we recognize this, the workplace dynamic transformsimproving not only the atmosphere but also overall performance.
By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive. The post How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergencies appeared first on MedCity News.
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
The agency is still unclear about where it will stand on clinical trial diversity, but companies are looking for answers and leaning toward good science.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. It has transformed into a dynamic dialogue that empowers individuals, personalizes content, and integrates cutting-edge digital tools. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment.
Pharma and Marketing in a New Era Discussing customer-centricity in the ever-evolving technological landscape of healthcare. On September 30, 2024, we gathered our 2024 Trailblazer Brand Champions and Marketer of the Year for a roundtable discussion sponsored by Concentric Life, centered mainly around customer- versus product-centricity in our industry, AI and technological implementation in marketing and pharma, patient empowerment strategies, cross-functional collaboration, social listening, d
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
276 
Let's personalize your content